Literature DB >> 14766976

Genetic diversity and virulence potential of environmental Vibrio cholerae population in a cholera-endemic area.

Shah M Faruque1, Nityananda Chowdhury, M Kamruzzaman, Michelle Dziejman, M Hasibur Rahman, David A Sack, G Balakrish Nair, John J Mekalanos.   

Abstract

To understand the evolutionary events and possible selection mechanisms involved in the emergence of pathogenic Vibrio cholerae, we analyzed diverse strains of V. cholerae isolated from environmental waters in Bangladesh by direct enrichment in the intestines of adult rabbits and by conventional laboratory culture. Strains isolated by conventional culture were mostly (99.2%) negative for the major virulence gene clusters encoding toxin-coregulated pilus (TCP) and cholera toxin (CT) and were nonpathogenic in animal models. In contrast, all strains selected in rabbits were competent for colonizing infant mice, and 56.8% of these strains carried genes encoding TCP alone or both TCP and CT. Ribotypes of toxigenic O1 and O139 strains from the environment were similar to pandemic strains, whereas ribotypes of non-O1 non-O139 strains and TCP(-) nontoxigenic O1 strains diverged widely from the seventh pandemic O1 and the O139 strains. Results of this study suggest that (i) the environmental V. cholerae population in a cholera-endemic area is highly heterogeneous, (ii) selection in the mammalian intestine can cause enrichment of environmental strains with virulence potential, (iii) pathogenicity of V. cholerae involves more virulence genes than currently appreciated, and (iv) most environmental V. cholerae strains are unlikely to attain a pandemic potential by acquisition of TCP and CT genes alone. Because most of the recorded cholera pandemics originated in the Ganges Delta region, this ecological setting presumably favors extensive genetic exchange among V. cholerae strains and thus promotes the rare, multiple-gene transfer events needed to assemble the critical combination of genes required for pandemic spread.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766976      PMCID: PMC357062          DOI: 10.1073/pnas.0308485100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Genomic profiles of clinical and environmental isolates of Vibrio cholerae O1 in cholera-endemic areas of Bangladesh.

Authors:  Young-Gun Zo; Irma N G Rivera; Estelle Russek-Cohen; M Sirajul Islam; A K Siddique; M Yunus; R Bradley Sack; Anwar Huq; Rita R Colwell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-30       Impact factor: 11.205

2.  Characterization of VPI pathogenicity island and CTXphi prophage in environmental strains of Vibrio cholerae.

Authors:  A K Mukhopadhyay; S Chakraborty; Y Takeda; G B Nair; D E Berg
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

3.  RS1 element of Vibrio cholerae can propagate horizontally as a filamentous phage exploiting the morphogenesis genes of CTXphi.

Authors:  Shah M Faruque; M Kamruzzaman; Ranjan K Nandi; A N Ghosh; G Balakrish Nair; John J Mekalanos; David A Sack
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli.

Authors:  J Brosius; A Ullrich; M A Raker; A Gray; T J Dull; R R Gutell; H F Noller
Journal:  Plasmid       Date:  1981-07       Impact factor: 3.466

5.  Microtiter ganglioside enzyme-linked immunosorbent assay for vibrio and Escherichia coli heat-labile enterotoxins and antitoxin.

Authors:  D A Sack; S Huda; P K Neogi; R R Daniel; W M Spira
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

6.  Evolutionary and functional analyses of variants of the toxin-coregulated pilus protein TcpA from toxigenic Vibrio cholerae non-O1/non-O139 serogroup isolates.

Authors:  E Fidelma Boyd; Matthew K Waldor
Journal:  Microbiology       Date:  2002-06       Impact factor: 2.777

7.  Pathogenic potential of environmental Vibrio cholerae strains carrying genetic variants of the toxin-coregulated pilus pathogenicity island.

Authors:  Shah M Faruque; M Kamruzzaman; Ismail M Meraj; Nityananda Chowdhury; G Balakrish Nair; R Bradley Sack; Rita R Colwell; David A Sack
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 8.  Pathogenicity islands and phages in Vibrio cholerae evolution.

Authors:  Shah M Faruque; John J Mekalanos
Journal:  Trends Microbiol       Date:  2003-11       Impact factor: 17.079

9.  Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea.

Authors:  W M Spira; R B Sack; J L Froehlich
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

10.  Reemergence of epidemic Vibrio cholerae O139, Bangladesh.

Authors:  Shah M Faruque; Nityananda Chowdhury; M Kamruzzaman; Q Shafi Ahmad; A S G Faruque; M Abdus Salam; T Ramamurthy; G Balakrish Nair; Andrej Weintraub; David A Sack
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

View more
  81 in total

1.  Emergence of multidrug-resistant Vibrio cholerae O1 biotype El Tor in Port Blair, India.

Authors:  Debdutta Bhattacharya; D S Sayi; R Thamizhmani; Haimanti Bhattacharjee; A P Bharadwaj; Avijit Roy; A P Sugunan
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Microarray-based detection of genetic heterogeneity, antimicrobial resistance, and the viable but nonculturable state in human pathogenic Vibrio spp.

Authors:  Gary J Vora; Carolyn E Meador; Michele M Bird; Cheryl A Bopp; Joanne D Andreadis; David A Stenger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-14       Impact factor: 11.205

3.  Enterotoxigenicity of mature 45-kilodalton and processed 35-kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain.

Authors:  A Ghosh; D R Saha; K M Hoque; M Asakuna; S Yamasaki; H Koley; S S Das; M K Chakrabarti; A Pal
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

4.  Identification of Vibrio cholerae type III secretion system effector proteins.

Authors:  Ashfaqul Alam; Kelly A Miller; Mudit Chaand; J Scott Butler; Michelle Dziejman
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

5.  RTX toxin actin cross-linking activity in clinical and environmental isolates of Vibrio cholerae.

Authors:  Christina L Cordero; Shanmuga Sozhamannan; Karla J Fullner Satchell
Journal:  J Clin Microbiol       Date:  2007-05-23       Impact factor: 5.948

Review 6.  MARTX, multifunctional autoprocessing repeats-in-toxin toxins.

Authors:  Karla J Fullner Satchell
Journal:  Infect Immun       Date:  2007-07-23       Impact factor: 3.441

7.  Inactivation of small Rho GTPases by the multifunctional RTX toxin from Vibrio cholerae.

Authors:  Kerri-Lynn Sheahan; Karla J Fullner Satchell
Journal:  Cell Microbiol       Date:  2007-05       Impact factor: 3.715

8.  Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin.

Authors:  Stefan Pukatzki; Amy T Ma; Andrew T Revel; Derek Sturtevant; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

9.  Observed Handwashing with Soap Practices Among Cholera Patients and Accompanying Household Members in a Hospital Setting (CHoBI7 Trial).

Authors:  Fatema Zohura; Sazzadul Islam Bhuyian; Shirajum Monira; Farzana Begum; Shwapon K Biswas; Tahmina Parvin; David Sack; R Bradley Sack; Elli Leontsini; K M Saif-Ur-Rahman; Mahamud-Ur Rashid; Rumana Sharmin; Xiaotong Zhang; Munirul Alam; Christine Marie George
Journal:  Am J Trop Med Hyg       Date:  2016-10-03       Impact factor: 2.345

10.  Quorum-regulated biofilms enhance the development of conditionally viable, environmental Vibrio cholerae.

Authors:  M Kamruzzaman; S M Nashir Udden; D Ewen Cameron; Stephen B Calderwood; G Balakrish Nair; John J Mekalanos; Shah M Faruque
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.